[February 13, 2018] |
|
MetLife Announces Fourth Quarter and Full Year 2017 Results
MetLife, Inc. (NYSE: MET) today announced its results for the fourth
quarter and full year ended December 31, 2017.
Fourth Quarter Results Summary
-
Net income of $2.1 billion, compared to a loss of $2.2 billion in the
fourth quarter of 2016. On a per share basis, net income was $1.97,
compared to a loss of $2.03 in the prior-year period.
-
Adjusted Earnings* of $678 million, or $0.64 per share.
-
Book value was $53.57 per share down 10 percent from $59.35 per share
at December 31, 2016, primarily due to the separation of Brighthouse
Financial, Inc. and its subsidiaries (Brighthouse).
-
Book value, excluding accumulated other comprehensive income (AOCI)
other than foreign currency translation adjustments (FCTA)*, was
$42.24 per share, down 15 percent from $49.61 per share at
December 31, 2016.
-
Return on Equity (ROE) of 15.2 percent.
-
Adjusted ROE*, excluding AOCI other than FCTA, of 6.2 percent;
Adjusted tangible ROE* of 8.1 percent.
Full Year Results Summary
-
Net income of $3.6 billion, compared to net income of $627 million for
the full year 2016. On a per share basis, net income was $3.38, up
from $0.57 for the full year 2016.
-
Adjusted Earnings* of $4.2 billion, or $3.93 per share.
-
ROE of 5.9 percent.
-
Adjusted ROE*, excluding AOCI other than FCTA, of 8.5 percent for the
full year 2017; Adjusted tangible ROE* of 10.6 percent.
"Although our underlying financial performance remained solid, the
reserve charge and its impact on our fourth quarter and full year
earnings - as well as the material weakness that led us to delay our
earnings announcement - are unacceptable and deeply disappointing," said
Steven A. Kandarian, chairman, president and CEO of MetLife, Inc. "We
can and will do better. We are rigorously addressing the situation and
are committed to significantly improving our operational performance to
better serve our customers and strengthen shareholders' confidence in
our organization. MetLife is an iconic franchise with strong businesses,
and we are working very hard to continue to successfully execute on our
strategy and deliver great value to our customers and shareholders."
Fourth Quarter & Full Year 2017 Summary
|
|
|
|
|
|
|
(In millions, except per share data)
|
|
|
|
Three months ended December 31,
|
|
Year ended
December 31,
|
|
|
|
|
2017
|
|
2016
|
|
Change
|
|
2017
|
|
2016
|
|
Change
|
Premiums, fees & other revenues
|
|
|
|
$11,335
|
|
$10,977
|
|
3%
|
|
$45,843
|
|
$44,370
|
|
3%
|
Net investment income
|
|
|
|
4,454
|
|
4,263
|
|
4%
|
|
17,363
|
|
16,790
|
|
3%
|
Net investment gains (losses)
|
|
|
|
106
|
|
(299)
|
|
|
|
(308)
|
|
317
|
|
|
Net derivative gains (losses)
|
|
|
|
(141)
|
|
(2,312)
|
|
94%
|
|
(804)
|
|
(874)
|
|
8%
|
Total revenues
|
|
|
|
$15,754
|
|
$12,629
|
|
25%
|
|
$62,094
|
|
$60,603
|
|
2%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total adjusted revenues
|
|
|
|
$15,403
|
|
$15,272
|
|
1%
|
|
$62,744
|
|
$60,916
|
|
3%
|
Adjusted premiums, fees & other revenues
|
|
|
|
$11,300
|
|
$11,136
|
|
1%
|
|
$46,200
|
|
$44,479
|
|
4%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss)
|
|
|
|
$2,091
|
|
$(2,230)
|
|
|
|
$3,643
|
|
$627
|
|
|
Net income (loss) per share
|
|
|
|
$1.97
|
|
$(2.03)
|
|
|
|
$3.38
|
|
$0.57
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted earnings
|
|
|
|
$678
|
|
$1,057
|
|
(36)%
|
|
$4,235
|
|
$4,033
|
|
5%
|
Adjusted earnings per share
|
|
|
|
$0.64
|
|
$0.95
|
|
(33)%
|
|
$3.93
|
|
$3.64
|
|
8%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Book value per share
|
|
|
|
$53.57
|
|
$59.35
|
|
(10)%
|
|
$53.57
|
|
$59.35
|
|
(10)%
|
Book value per share, excluding AOCI other than FCTA
|
|
|
|
$42.24
|
|
$49.61
|
|
(15)%
|
|
$42.24
|
|
$49.61
|
|
(15)%
|
Book value per share - tangible common stockholders' equity
|
|
|
|
$32.95
|
|
$40.92
|
|
(19)%
|
|
$32.95
|
|
$40.92
|
|
(19)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ROE
|
|
|
|
15.2%
|
|
(12.6)%
|
|
|
|
5.9%
|
|
0.9%
|
|
|
ROE, excluding AOCI other than FCTA
|
|
|
|
19.2%
|
|
(15.8)%
|
|
|
|
7.3%
|
|
1.1%
|
|
|
Tangible ROE
|
|
|
|
24.8%
|
|
(19.0)%
|
|
|
|
9.1%
|
|
1.4%
|
|
|
Adjusted ROE, excluding AOCI other than FCTA
|
|
|
|
6.2%
|
|
7.5%
|
|
|
|
8.5%
|
|
7.1%
|
|
|
Adjusted tangible ROE
|
|
|
|
8.1%
|
|
9.1%
|
|
|
|
10.6%
|
|
8.6%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MetLife reported fourth quarter 2017 net income of $2.1 billion,
compared to a loss of $2.2 billion in the fourth quarter of 2016.
Net income includes (1) a $70 million, after tax, charge in relation to
increasing certain Retirement and Income Solutions (RIS) policy
reserves, and (2) $1.2 billion, after tax, benefit related to the impact
of the U.S. tax reform which includes a negative impact to adjusted
earnings of $298 million. On a per share basis, net income was $1.97,
compared to a loss of $2.03 in the prior-year period.
The results include revised prior period numbers to reflect a reserve
strengthening and other corrections in the appropriate historical
periods as previously discussed in the press release preannouncing
preliminary fourth quarter 2017 earnings issued on January 29, 2018.
Net derivative losses amounted to $92 million after tax during the
quarter.
Premiums, fees & other revenues were $11.3 billion, up 3 percent over
the fourth quarter of 2016. Adjusted premiums, fees & other revenues*
were $11.3 billion, up 1 percent, and 1 percent on a constant currency
basis over the prior-year period.
MetLife reported adjusted earnings of $678 million, down 36 percent from
the fourth quarter of 2016, and 36 percent on a constant currency
basis*. On a per share basis, adjusted earnings were $0.64, down
33 percent from the prior-year period.
For the full year 2017, MetLife reported net income of $3.6 billion,
compared to net income of $627 million for the full year 2016. Net
income includes (1) a $90 million, after tax, charge related to the
above mentioned increase of certain RIS policy reserves, (2) the above
mentioned U.S. tax reform impact, and (3) $1.3 billion in Brighthouse
separation charges.
Full year 2017 adjusted earnings were $4.2 billion, up 5 percent. On a
per share basis, 2017 adjusted earnings were $3.93, up 8 percent over
2016.
Supplemental slides for the fourth quarter of 2017, titled "4Q17
Supplemental Slides," are available on the MetLife Investor Relations
website at www.metlife.com
in the Conferences & Presentations section, and in the Form 8-K
furnished by MetLife to the U.S. Securities and Exchange Commission
(SEC) in connection with this earnings news release.
Adjusted Earnings by Segment Summary
|
|
|
|
|
|
|
|
|
Three months ended
December 31, 2017
|
|
Year ended
December 31, 2017
|
Segment
|
|
|
Change from prior-year period
|
|
Change (from prior-year period on a
constant currency basis)
|
|
Change from prior-year
|
|
Change (from prior-year on a constant
currency basis)
|
U.S.
|
|
|
(3)%
|
|
(3)%
|
|
7%
|
|
7%
|
Asia
|
|
|
(12)%
|
|
(12)%
|
|
-%
|
|
1%
|
Latin America
|
|
|
2%
|
|
0%
|
|
8%
|
|
8%
|
Europe, the Middle East and Africa (EMEA)
|
|
|
10%
|
|
5%
|
|
9%
|
|
14%
|
MetLife Holdings
|
|
|
(3)%
|
|
(3)%
|
|
67%
|
|
67%
|
|
|
|
|
|
|
|
|
|
|
Business Discussions
All comparisons of the results for the fourth quarter of 2017 in the
business discussions that follow are with the fourth quarter of 2016,
unless otherwise noted. See fourth quarter 2017 notable items table that
follows at the end of the business discussion section of this release
for additional information on notables incurred in the fourth quarter of
2017.
U.S.
|
|
|
|
|
|
|
|
(In millions)
|
|
|
Three months ended December 31, 2017
|
|
Three months ended December 31, 2016
|
|
Change
|
Adjusted earnings
|
|
|
$498
|
|
$511
|
|
(3)%
|
Adjusted premiums, fees & other revenues
|
|
|
$6,038
|
|
$5,815
|
|
4%
|
Adjusted premiums, fees & other revenues, excluding pension risk
transfers
|
|
|
$5,441
|
|
$5,305
|
|
3%
|
Notable item(s)
|
|
|
$(55)
|
|
$-
|
|
|
|
|
|
|
|
|
|
|
-
Total adjusted earnings for the U.S. were $498 million, down
3 percent, primarily reflecting the previously mentioned charge in
relation to increasing certain RIS policy reserves. Notable items in
the current period include the previously mentioned charge in RIS and
favorable prior-year development in Property & Casualty.
-
Excluding notable items in the fourth quarter of 2017, adjusted
earnings were up 8 percent driven by favorable underwriting, expenses
and volume growth, partially offset by lower interest margin.
-
Adjusted return on allocated equity was 19.5 percent, and
adjusted return on allocated tangible equity was 22.7 percent.
-
Adjusted premiums, fees & other revenues were $6.0 billion,
up 4 percent. Excluding pension risk transfers, adjusted premiums,
fees & other revenues were up 3 percent.
Group Benefits
|
|
|
|
|
|
|
|
(In millions)
|
|
|
Three months ended December 31, 2017
|
|
Three months ended December 31, 2016
|
|
Change
|
Adjusted earnings
|
|
|
$230
|
|
$174
|
|
32%
|
Adjusted premiums, fees & other revenues
|
|
|
$4,105
|
|
$4,033
|
|
2%
|
Notable item(s)
|
|
|
$-
|
|
$-
|
|
|
|
|
|
|
|
|
|
|
-
Adjusted earnings for Group Benefits were $230 million, up 32
percent, driven by strong non-medical health underwriting and
favorable expenses.
-
Adjusted premiums, fees & other revenues were $4.1 billion,
up 2 percent.
-
Sales for Group Benefits were up 19 percent for the full year
2017 driven by significant jumbo case activity.
Retirement and Income Solutions
|
|
|
|
|
|
|
|
(In millions)
|
|
|
Three months ended December 31, 2017
|
|
Three months ended December 31, 2016
|
|
Change
|
Adjusted earnings
|
|
|
$173
|
|
$294
|
|
(41)%
|
Adjusted premiums, fees & other revenues
|
|
|
$1,026
|
|
$895
|
|
15%
|
Notable item(s)
|
|
|
$(62)
|
|
$-
|
|
|
|
|
|
|
|
|
|
|
-
Adjusted earnings for Retirement and Income Solutions were
$173 million, down 41 percent, primarily reflecting the previously
mentioned charge in relation to increasing certain RIS policy reserves
which is a notable item in the current period.
-
Excluding notable items in the fourth quarter of 2017, adjusted
earnings were down 20 percent, driven by lower interest and
underwriting margins, partially offset by volume growth and lower
expenses.
-
Adjusted premiums, fees & other revenues were $1.0 billion,
up 15 percent from the prior-year period, driven by pension risk
transfer and structured settlement sales.
-
Excluding pension risk transfers, adjusted premiums, fees & other
revenues were up 11 percent.
Property & Casualty
|
|
|
|
|
|
|
|
(In millions)
|
|
|
Three months ended December 31, 2017
|
|
Three months ended December 31, 2016
|
|
Change
|
Adjusted earnings
|
|
|
$95
|
|
$43
|
|
121%
|
Adjusted premiums, fees & other revenues
|
|
|
$907
|
|
$887
|
|
2%
|
Notable item(s)
|
|
|
$7
|
|
$-
|
|
|
|
|
|
|
|
|
|
|
-
Adjusted earnings for Property & Casualty increased from
$43 million to $95 million, up 121 percent, primarily due to favorable
auto underwriting results. The notable item in the current period
reflects favorable prior-year development.
-
Adjusted premiums, fees & other revenues were $907 million,
up 2 percent.
-
Property & Casualty sales were $133 million, up 16 percent.
ASIA
|
|
|
|
|
|
|
|
(In millions)
|
|
|
Three months ended December 31, 2017
|
|
Three months ended December 31, 2016
|
|
Change
|
Adjusted earnings
|
|
|
$310
|
|
$354
|
|
(12)%
|
Adjusted earnings (constant currency)
|
|
|
$310
|
|
$353
|
|
(12)%
|
Adjusted premiums, fees & other revenues
|
|
|
$2,088
|
|
$2,130
|
|
(2)%
|
Notable item(s)
|
|
|
$-
|
|
$-
|
|
|
|
|
|
|
|
|
|
|
-
Adjusted earnings for Asia were $310 million, down 12 percent
on both a reported and a constant currency basis, impacted by a change
in Japan's effective tax rate, and the reversal of a tax accrual in
the prior-year period.
-
Adjusted return on allocated equity was 9.9 percent, and
adjusted return on allocated tangible equity was 15.8 percent.
-
Adjusted premiums fees & other revenues were $2.1 billion,
down 2 percent on a reported basis and unchanged on a constant
currency basis.
-
Total sales for the region were $611 million, up 1 percent on a
constant currency basis. Emerging markets were up 26 percent on a
constant currency basis, primarily due to strong agency growth in
China.
LATIN AMERICA
|
|
|
|
|
|
|
|
(In millions)
|
|
|
Three months ended December 31, 2017
|
|
Three months ended December 31, 2016
|
|
Change
|
Adjusted earnings
|
|
|
$125
|
|
$122
|
|
2%
|
Adjusted earnings (constant currency)
|
|
|
$125
|
|
$125
|
|
-%
|
Adjusted premiums, fees & other revenues
|
|
|
$988
|
|
$913
|
|
8%
|
Notable item(s)
|
|
|
$-
|
|
$-
|
|
|
|
|
|
|
|
|
|
|
-
Adjusted earnings for Latin America were $125 million, up 2
percent, and unchanged on a constant currency basis, with volume
growth partially offset by higher expenses and taxes.
-
Adjusted return on allocated equity was 17.0 percent, and
adjusted return on allocated tangible equity was 29.3 percent.
-
Adjusted premiums, fees & other revenues were $988 million,
up 8 percent, and 5 percent on a constant currency basis.
-
Total sales for the region were down 1 percent on a constant
currency basis, as strong direct marketing sales in the quarter were
more than offset by a large group life sale in Mexico in the
prior-year period.
EMEA
|
|
|
|
|
|
|
|
(In millions)
|
|
|
Three months ended December 31, 2017
|
|
Three months ended December 31, 2016
|
|
Change
|
Adjusted earnings
|
|
|
$79
|
|
$72
|
|
10%
|
Adjusted earnings (constant currency)
|
|
|
$79
|
|
$75
|
|
5%
|
Adjusted premiums, fees & other revenues
|
|
|
$651
|
|
$622
|
|
5%
|
Notable item(s)
|
|
|
$-
|
|
$-
|
|
|
|
|
|
|
|
|
|
|
-
Adjusted earnings for EMEA were $79 million, up 10 percent, and
5 percent on a constant currency basis, driven by volume growth in
Turkey and Western Europe, and favorable expenses.
-
Adjusted return on allocated equity was 9.8 percent, and
adjusted return on allocated tangible equity was 16.1 percent.
-
Adjusted premiums, fees & other revenues were $651 million,
up 5 percent on a reported basis and up 1 percent on a constant
currency basis.
-
Total sales for the region were $231 million, down 1 percent on
a constant currency basis. Excluding the impact from the recently
exited UK wealth management business, sales were up 8 percent.
METLIFE HOLDINGS
|
|
|
|
|
|
|
|
(In millions)
|
|
|
Three months ended December 31, 2017
|
|
Three months ended December 31, 2016
|
|
Change
|
Adjusted earnings
|
|
|
$194
|
|
$201
|
|
(3)%
|
Adjusted premiums, fees & other revenues
|
|
|
$1,453
|
|
$1,626
|
|
(11)%
|
Notable item(s)
|
|
|
$(48)
|
|
$(91)
|
|
|
|
|
|
|
|
|
|
|
-
Adjusted earnings for MetLife Holdings were
$194 million, down 3 percent, driven mainly by lower interest margin
and the impact of notable adjustments recorded in the current and
prior periods. The notable item in the current period reflects an
actuarial reserve adjustment.
-
Excluding notable items from both periods, adjusted earnings
were down 17 percent, primarily due to lower interest margin and
higher expenses.
-
Adjusted return on allocated equity was 6.9 percent, and
adjusted return on allocated tangible equity was 7.8 percent.
-
Adjusted premiums, fees & other revenues were
$1.5 billion, down 11% percent, mostly due to the Brighthouse
separation impacts.
CORPORATE & OTHER
|
|
|
|
|
|
|
|
(In millions)
|
|
|
Three months ended December 31, 2017
|
|
Three months ended December 31, 2016
|
|
Change
|
Adjusted earnings
|
|
|
$(528)
|
|
$(203)
|
|
|
Notable item(s)
|
|
|
$(395)
|
|
$(51)
|
|
|
|
|
|
|
|
|
|
|
-
Corporate & Other had an adjusted loss of $528 million,
compared to an adjusted loss of $203 million in the fourth quarter of
2016. Notable items in the current period include the impact of the
tax reform, expenses associated with the company's previously
announced cost saving initiatives and litigation expenses.
INVESTMENTS
|
|
|
|
|
|
|
|
(In millions)
|
|
|
Three months ended December 31, 2017
|
|
Three months ended December 31, 2016
|
|
Change
|
Net investment income (as reported on an adjusted basis)
|
|
|
$4,103
|
|
$4,136
|
|
(1)%
|
|
|
|
|
|
|
|
|
-
As reported on an adjusted basis, net investment income was
$4.1 billion, down 1 percent. Variable investment income was
$216 million ($140 million, after tax and DAC), as compared to
$244 million ($159 million, after tax and DAC) in the fourth quarter
of 2016, due to weaker alternative investments performance and lower
prepayments.
-
Derivative net losses of $147 million, after tax, were driven
by changes in foreign currencies and interest rates. Derivative net
losses in the fourth quarter of 2016 were $1.7 billion, after tax.
FOURTH QUARTER 2017 NOTABLE ITEMS
|
|
|
|
(In millions)
|
|
|
Adjusted Earnings
|
|
|
Three months ended December 31, 2017
|
Notable Items
|
|
|
U.S.
|
|
Asia
|
|
Latin
America
|
|
EMEA
|
|
MetLife
Holdings
|
|
Corporate
&
Other
|
|
Total
|
|
|
Group Benefits
|
|
Retirement and Income Solutions
|
|
Property &
Casualty
|
|
|
|
|
|
|
Catastrophe experience and prior year development, net
|
|
|
|
|
|
|
$7
|
|
|
|
|
|
|
|
|
|
|
|
$7
|
Actuarial assumption review and other insurance adjustments
|
|
|
|
|
$(62)
|
|
|
|
|
|
|
|
|
|
$(48)
|
|
|
|
$(110)
|
Litigation reserves & settlement costs
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$(55)
|
|
$(55)
|
Expense initiative costs
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$(42)
|
|
$(42)
|
Tax adjustments
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$(298)
|
|
$(298)
|
Total notable items
|
|
|
$-
|
|
$(62)
|
|
$7
|
|
$-
|
|
$-
|
|
$-
|
|
$(48)
|
|
$(395)
|
|
$(498)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
*Information regarding the non-GAAP and other financial measures
included in this news release and the reconciliation of the non-GAAP
financial measures to GAAP measures is provided in the Non-GAAP and
Other Financial Disclosures discussions below. Adjusted measures were
formerly referred to as operating measures.
About MetLife
MetLife, Inc. (NYSE: MET), through its subsidiaries and affiliates
("MetLife"), is one of the world's leading financial services companies,
providing insurance, annuities, employee benefits and asset management
to help its individual and institutional customers navigate their
changing world. Founded in 1868, MetLife has operations in more than 40
countries and holds leading market positions in the United States,
Japan, Latin America, Asia, Europe and the Middle East. For more
information, visit www.metlife.com.
Conference Call
MetLife will hold its fourth quarter 2017 earnings conference call and
audio webcast on Wednesday, Feb. 14, 2018, from 8-9 a.m. (EST). The
conference call will be available live via telephone and the internet.
To listen via telephone, dial 877-209-9920 (U.S.) or 612-332-0530
(outside the U.S.). To listen to the conference call via the internet,
visit www.metlife.com
through a link on the Investor Relations page. Those who want to listen
to the call via telephone or the internet should dial in or go to the
website at least 15 minutes prior to the call to register, and/or
download and install any necessary audio software.
The conference call will be available for replay via telephone and the
internet beginning at 10 a.m. (EST) on Wednesday, Feb. 14, 2018, until
Wednesday, Feb. 21, 2018, at 11:59 p.m. (EST). To listen to a replay of
the conference call via telephone, dial 800-475-6701 (U.S.) or
320-365-3844 (outside the U.S.). The access code for the replay is
433148. To access the replay of the conference call over the internet,
visit the above-mentioned website.
Non-GAAP and Other Financial Disclosures
Any references in this news release (except in this
section and the tables that accompany this release) to:
|
|
should be read as, respectively:
|
|
|
|
|
(i)
|
net income (loss);
|
|
(i)
|
net income (loss) available to MetLife, Inc.'s common shareholders;
|
|
|
|
|
|
(ii)
|
net income (loss) per share;
|
|
(ii)
|
net income (loss) available to MetLife, Inc.'s common shareholders
per diluted common share;
|
|
|
|
|
|
(iii)
|
adjusted earnings;
|
|
(iii)
|
adjusted earnings available to common shareholders;
|
|
|
|
|
|
(iv)
|
adjusted earnings per share;
|
|
(iv)
|
adjusted earnings available to common shareholders per diluted
common share;
|
|
|
|
|
|
(v)
|
book value per share;
|
|
(v)
|
book value per common share;
|
|
|
|
|
|
(vi)
|
book value per share, excluding AOCI other than FCTA;
|
|
(vi)
|
book value per common share, excluding AOCI other than FCTA;
|
|
|
|
|
|
(vii)
|
book value per share-tangible common stockholders' equity;
|
|
(vii)
|
book value per common share-tangible common stockholders' equity;
|
|
|
|
|
|
(viii)
|
premiums, fees and other revenues;
|
|
(viii)
|
premiums, fees and other revenues (adjusted);
|
|
|
|
|
|
(ix)
|
return on equity;
|
|
(ix)
|
return on MetLife, Inc.'s common stockholders' equity;
|
|
|
|
|
|
(x)
|
return on equity, excluding AOCI other than FCTA;
|
|
(x)
|
return on MetLife, Inc.'s common stockholders' equity, excluding
AOCI, other than FCTA;
|
|
|
|
|
|
(xi)
|
adjusted return on equity, excluding AOCI other than FCTA;
|
|
(xi)
|
adjusted return on MetLife, Inc.'s common stockholders' equity,
excluding AOCI other than FCTA;
|
|
|
|
|
|
(xii)
|
tangible return on equity; and
|
|
(xii)
|
return on MetLife, Inc.'s tangible common stockholders' equity; and
|
|
|
|
|
|
(xiii)
|
adjusted tangible return on equity.
|
|
(xiii)
|
adjusted return on MetLife, Inc.'s tangible common stockholders'
equity.
|
|
|
|
|
|
In this news release, MetLife presents certain measures of its
performance that are not calculated in accordance with accounting
principles generally accepted in the United States of America ("GAAP").
MetLife believes that these non-GAAP financial measures enhance the
understanding of MetLife's performance by highlighting the results of
operations and the underlying profitability drivers of the business. The
following non-GAAP financial measures should not be viewed as
substitutes for the most directly comparable financial measures
calculated in accordance with GAAP:
Non-GAAP financial measures:
|
|
Comparable GAAP financial measures:
|
|
|
|
|
(i)
|
adjusted revenues;
|
|
(i)
|
revenues;
|
|
|
|
|
|
(ii)
|
adjusted expenses;
|
|
(ii)
|
expenses;
|
|
|
|
|
|
(iii)
|
adjusted premiums, fees and other revenues;
|
|
(iii)
|
premiums, fees and other revenues;
|
|
|
|
|
|
(iv)
|
adjusted earnings;
|
|
(iv)
|
income (loss) from continuing operations, net of income tax;
|
|
|
|
|
|
(v)
|
adjusted earnings available to common shareholders;
|
|
(v)
|
net income (loss) available to MetLife, Inc.'s common shareholders;
|
|
|
|
|
|
(vi)
|
adjusted earnings available to common shareholders on a constant
currency basis;
|
|
(vi)
|
net income (loss) available to MetLife, Inc.'s common shareholders;
|
|
|
|
|
|
(vii)
|
adjusted earnings available to common shareholders, excluding total
notable items;
|
|
(vii)
|
net income (loss) available to MetLife, Inc.'s common shareholders;
|
|
|
|
|
|
(viii)
|
adjusted earnings available to common shareholders, excluding total
notable items, on a constant currency basis;
|
|
(viii)
|
net income (loss) available to MetLife, Inc.'s common shareholders;
|
|
|
|
|
|
(ix)
|
adjusted earnings available to common shareholders per diluted
common share;
|
|
(ix)
|
net income (loss) available to MetLife, Inc.'s common shareholders
per diluted common share;
|
|
|
|
|
|
(x)
|
adjusted earnings available to common shareholders, excluding total
notable items per diluted common share;
|
|
(x)
|
net income (loss) available to MetLife, Inc.'s common shareholders
per diluted common share;
|
|
|
|
|
|
(xi)
|
adjusted earnings available to common shareholders, excluding total
notable items, on a constant currency basis per diluted common share;
|
|
(xi)
|
net income (loss) available to MetLife, Inc.'s common shareholders
per diluted common share;
|
|
|
|
|
|
(xii)
|
adjusted return on equity;
|
|
(xii)
|
return on equity;
|
|
|
|
|
|
(xiii)
|
adjusted return on equity, excluding AOCI other than FCTA;
|
|
(xiii)
|
return on equity;
|
|
|
|
|
|
(xiv)
|
adjusted tangible ROE;
|
|
(xiv)
|
return on equity;
|
|
|
|
|
|
(xv)
|
investment portfolio gains (losses);
|
|
(xv)
|
net investment gains (losses);
|
|
|
|
|
|
(xvi)
|
derivative gains (losses);
|
|
(xvi)
|
net derivative gains (losses);
|
|
|
|
|
|
(xvii)
|
MetLife, Inc.'s tangible common stockholders' equity;
|
|
(xvii)
|
MetLife, Inc.'s stockholders' equity;
|
|
|
|
|
|
(xviii)
|
MetLife, Inc.'s tangible common stockholders' equity, excluding
total notable items;
|
|
(xviii)
|
MetLife, Inc.'s stockholders' equity;
|
|
|
|
|
|
(xix)
|
MetLife, Inc.'s common stockholders' equity, excluding AOCI other
than FCTA;
|
|
(xix)
|
MetLife, Inc.'s stockholders' equity;
|
|
|
|
|
|
(xx)
|
MetLife, Inc.'s common stockholders' equity, excluding total notable
items (excludes AOCI other than FCTA);
|
|
(xx)
|
MetLife, Inc.'s stockholders' equity;
|
|
|
|
|
|
(xxi)
|
MetLife, Inc.'s common stockholders' equity, excluding net equity of
assets and liabilities of disposed subsidiary (excludes AOCI other
than FCTA);
|
|
(xxi)
|
MetLife, Inc.'s stockholders' equity;
|
|
|
|
|
|
(xxii)
|
Adjusted return on allocated tangible equity - adjusted earnings
available to common shareholders, excluding amortization of VODA and
VOCRA, net of income tax, divided by allocated tangible equity; and
|
|
(xxii)
|
return on equity; and
|
|
|
|
|
|
(xxiii)
|
free cash flow of all holding companies.
|
|
(xxiii)
|
MetLife, Inc.'s net cash provided by (used in) adjusted activities.
|
|
|
|
|
|
Reconciliations of these non-GAAP measures to the most directly
comparable GAAP measures are included in this earnings news release and
in this period's quarterly financial supplement, which is available at www.metlife.com.
MetLife's definitions of the various non-GAAP and other financial
measures discussed in this news release may differ from those used by
other companies:
Adjusted earnings and related measures
-
adjusted earnings;
-
adjusted earnings available to common shareholders;
-
adjusted earnings available to common shareholders on a constant
currency basis;
-
adjusted earnings available to common shareholders, excluding total
notable items;
-
adjusted earnings available to common shareholders, excluding total
notable items, on a constant currency basis ;
-
adjusted earnings available to common shareholders per diluted common
share;
-
adjusted earnings available to common shareholders, excluding total
notable items per diluted common share; and
-
adjusted earnings available to common shareholders, excluding total
notable items, on a constant currency basis per diluted common share;
These measures are used by management to evaluate performance and
allocate resources. Consistent with GAAP guidance for segment reporting,
adjusted earnings is also MetLife's GAAP measure of segment performance.
Adjusted earnings and other financial measures based on adjusted
earnings are also the measures by which MetLife senior management's and
many other employees' performance is evaluated for the purposes of
determining their compensation under applicable compensation plans.
Adjusted earnings and other financial measures based on adjusted
earnings allow analysis of our performance relative to our business plan
and facilitate comparisons to industry results.
Adjusted earnings is defined as adjusted revenues less adjusted
expenses, both net of income tax. Adjusted earnings available to common
shareholders is defined as adjusted earnings less preferred stock
dividends.
Adjusted revenues and adjusted expenses
These financial measures, along with the related adjusted premiums, fees
and other revenues, focus on our primary businesses principally by
excluding the impact of market volatility, which could distort trends,
and revenues and costs related to non-core products and certain entities
required to be consolidated under GAAP. Also, these measures exclude
results of discontinued operations under GAAP and other businesses that
have been or will be sold or exited by MetLife but do not meet the
discontinued operations criteria under GAAP and are referred to as
divested businesses. Divested businesses also includes the net impact of
transactions with exited businesses that have been eliminated in
consolidation under GAAP and costs relating to businesses that have been
or will be sold or exited by MetLife that do not meet the criteria to be
included in results of discontinued operations under GAAP. In addition,
for the year ended December 31, 2016, adjusted revenues and adjusted
expenses exclude the financial impact of converting MetLife's Japan
operations to calendar-year end reporting without retrospective
application of this change to prior periods and is referred to as lag
elimination. Adjusted revenues also excludes net investment gains
(losses) (NIGL) and net derivative gains (losses) (NDGL). Adjusted
expenses also excludes goodwill impairments.
The following additional adjustments are made to revenues, in the line
items indicated, in calculating adjusted revenues:
-
Universal life and investment-type product policy fees excludes the
amortization of unearned revenue related to NIGL and NDGL and certain
variable annuity guaranteed minimum income benefits (GMIB) fees (GMIB
fees);
-
Net investment income: (i) includes earned income on derivatives and
amortization of premium on derivatives that are hedges of investments
or that are used to replicate certain investments but do not qualify
for hedge accounting treatment, (ii) excludes post-tax adjusted
earnings adjustments relating to insurance joint ventures accounted
for under the equity method, (iii) excludes certain amounts related to
contractholder-directed unit-linked investments, and (iv) excludes
certain amounts related to securitization entities that are variable
interest entities (VIEs) consolidated under GAAP; and
-
Other revenues are adjusted for settlements of foreign currency
earnings hedges.
The following additional adjustments are made to expenses, in the line
items indicated, in calculating adjusted expenses:
-
Policyholder benefits and claims and policyholder dividends excludes:
(i) changes in the policyholder dividend obligation related to NIGL
and NDGL, (ii) inflation-indexed benefit adjustments associated with
contracts backed by inflation-indexed investments and amounts
associated with periodic crediting rate adjustments based on the total
return of a contractually referenced pool of assets and other pass
through adjustments, (iii) benefits and hedging costs related to GMIBs
(GMIB costs), and (iv) market value adjustments associated with
surrenders or terminations of contracts (Market value adjustments);
-
Interest credited to policyholder account balances includes
adjustments for earned income on derivatives and amortization of
premium on derivatives that are hedges of policyholder account
balances but do not qualify for hedge accounting treatment and
excludes amounts related to net investment income earned on
contractholder-directed unit-linked investments;
-
Amortization of DAC and value of business acquired (VOBA) excludes
amounts related to: (i) NIGL and NDGL, (ii) GMIB fees and GMIB costs
and (iii) Market value adjustments;
-
Amortization of negative VOBA excludes amounts related to Market value
adjustments;
-
Interest expense on debt excludes certain amounts related to
securitization entities that are VIEs consolidated under GAAP; and
-
Other expenses excludes costs related to: (i) noncontrolling
interests, (ii) implementation of new insurance regulatory
requirements, and (iii) acquisition, integration and other costs.
Adjusted earnings also excludes the recognition of certain contingent
assets and liabilities that could not be recognized at acquisition or
adjusted for during the measurement period under GAAP business
combination accounting guidance.
The tax impact of the adjustments mentioned above are calculated net of
the U.S. or foreign statutory tax rate, which could differ from the
company's effective tax rate. Additionally, the provision for income tax
(expense) benefit also includes the impact related to the timing of
certain tax credits, as well as certain tax reforms.
Investment portfolio gains (losses) and derivative gains (losses)
These are measures of investment and hedging activity. Investment
portfolio gains (losses) principally excludes amounts that are reported
within net investment gains (losses) but do not relate to the
performance of the investment portfolio, such as gains (losses) on sales
and divestitures of businesses or goodwill impairment. Derivative gains
(losses) principally excludes earned income on derivatives and
amortization of premium on derivatives, where such derivatives are
either hedges of investments or are used to replicate certain
investments, and where such derivatives do not qualify for hedge
accounting. This earned income and amortization of premium is reported
within adjusted earnings and not within derivative gains (losses).
Return on equity, allocated equity, tangible equity and related
measures
-
MetLife, Inc.'s common stockholders' equity, excluding AOCI other than
FCTA: MetLife, Inc.'s common stockholders' equity, excluding the net
unrealized investment gains (losses) and defined benefit plans
adjustment components of AOCI, net of income tax.
-
MetLife, Inc.'s common stockholders' equity, excluding total notable
items (excludes AOCI other than FCTA).
-
Adjusted return on MetLife, Inc.'s common stockholders' equity,
excluding AOCI other than FCTA: adjusted earnings available to common
shareholders divided by MetLife, Inc.'s average common stockholders'
equity, excluding AOCI other than FCTA.
-
Adjusted return on MetLife, Inc.'s common stockholders' equity,
excluding net equity of assets and liabilities of disposed subsidiary
(excludes AOCI other than FCTA): adjusted earnings available to common
shareholders divided by MetLife, Inc.'s average common stockholders'
equity, excluding net assets and liabilities of disposed subsidiary
(excludes AOCI other than FCTA).
-
Adjusted return on MetLife, Inc.'s common stockholders' equity:
adjusted earnings available to common shareholders divided by MetLife,
Inc.'s average common stockholders' equity.
-
Return on MetLife, Inc.'s common stockholders' equity, excluding AOCI
other than FCTA: net income (loss) available to MetLife, Inc.'s common
shareholders divided by MetLife, Inc.'s average common stockholders'
equity, excluding AOCI other than FCTA.
-
Return on MetLife, Inc.'s common stockholders' equity: net income
(loss) available to MetLife, Inc.'s common shareholders divided by
MetLife, Inc.'s average common stockholders' equity.
-
Allocated equity: portion of MetLife, Inc.'s common stockholders'
equity that management allocates to each of its segments and
sub-segments based on local capital requirements and economic capital.
Economic capital is an internally developed risk capital model, the
purpose of which is to measure the risk in the business and to provide
a basis upon which capital is deployed. MetLife management
periodically reviews this model to ensure that it remains consistent
with emerging industry practice standards and the local capital
requirements; allocated equity may be adjusted if warranted by such
review. Allocated equity excludes the impact of AOCI other than FCTA.
-
Adjusted return on allocated equity: adjusted earnings available to
common shareholders divided by allocated equity.
-
Return on allocated equity: net income (loss) available to MetLife,
Inc.'s common shareholders divided by allocated equity.
The above measures represent a level of equity consistent with the view
that, in the ordinary course of business, we do not plan to sell most
investments for the sole purpose of realizing gains or losses. Also
refer to the utilization of adjusted earnings and other financial
measures based on adjusted earnings mentioned above.
-
MetLife, Inc.'s tangible common shareholders' equity or tangible
equity: MetLife, Inc.'s common stockholders' equity, excluding the net
unrealized investment gains (losses) and defined benefit plans
adjustment components of AOCI reduced by the impact of goodwill, value
of distribution agreements (VODA) and value of customer relationships
acquired (VOCRA), all net of income tax.
-
MetLife, Inc.'s tangible common stockholders' equity, adjusted for
total notable items.
-
Adjusted return on MetLife, Inc.'s tangible common stockholders'
equity: adjusted earnings available to common shareholders, excluding
amortization of VODA and VOCRA, net of income tax, divided by MetLife,
Inc.'s average tangible common stockholders' equity.
-
Return on MetLife, Inc.'s tangible common stockholders' equity: net
income (loss) available to MetLife, Inc.'s common shareholders,
excluding goodwill impairment and amortization of VODA and VOCRA, net
of income tax, divided by MetLife, Inc.'s average tangible common
stockholders' equity.
-
Adjusted return on allocated tangible equity: adjusted earnings
available to common shareholders, excluding amortization of VODA and
VOCRA, net of income tax, divided by allocated tangible equity.
-
Return on allocated tangible equity: net income (loss) available to
MetLife, Inc.'s common shareholders, excluding amortization of VODA
and VOCRA, net of income tax, divided by allocated tangible equity.
The above measures are, when considered in conjunction with regulatory
capital ratios, a measure of capital adequacy.
The following additional information is relevant to an
understanding of MetLife's performance results:
-
Adjusted expense ratio: calculated by dividing adjusted expenses
(other expenses, net of capitalization of DAC) by adjusted premiums,
fees and other revenues.
-
Statistical sales information for U.S. MetLife Holdings: calculated
(i) for life sales using the LIMRA definition of sales for core direct
sales, excluding company-sponsored internal exchanges, corporate-owned
life insurance, bank-owned life insurance, and private placement
variable universal life insurance, and (ii) annuity sales consist of
statutory premiums, excluding company sponsored internal exchanges.
Sales statistics do not correspond to revenues under GAAP, but are
used as relevant measures of business activity.
-
Statistical sales information for Latin America, Asia and EMEA:
calculated using 10% of single-premium deposits (mainly from
retirement products such as variable annuity, fixed annuity and
pensions), 20% of single-premium deposits from credit insurance and
100% of annualized full-year premiums and fees from recurring-premium
policy sales of all products (mainly from risk and protection products
such as individual life, accident & health and group). Sales
statistics do not correspond to revenues under GAAP, but are used as
relevant measures of business activity.
-
All comparisons on a constant currency basis reflect the impact of
changes in foreign currency exchange rates and are calculated using
the average foreign currency exchange rates for the current period and
are applied to each of the comparable periods.
-
Volume growth, as discussed in the context of business growth, is the
period over period percentage change in adjusted earnings available to
common shareholders attributable to adjusted premiums, fees and other
revenues and assets under management levels, applying a model in which
certain margins and factors are held constant. The most significant of
such items are underwriting margins, investment margins, changes in
equity market performance, expense margins and the impact of changes
in foreign currency exchange rates.
-
Asymmetrical and non-economic accounting refers to: (i) the portion of
net derivative gains (losses) on embedded derivatives attributable to
the inclusion of MetLife's credit spreads in the liability valuations,
(ii) hedging activity that generates net derivative gains (losses) and
creates fluctuations in net income because hedge accounting cannot be
achieved and the item being hedged does not a have an offsetting gain
or loss recognized in earnings, (iii) inflation-indexed benefit
adjustments associated with contracts backed by inflation-indexed
investments and amounts associated with periodic crediting rate
adjustments based on the total return of a contractually referenced
pool of assets and other pass through adjustments, and (iv) impact of
changes in foreign currency exchange rates on the re-measurement of
foreign denominated unhedged funding agreements and financing
transactions to the U.S. dollar and the re-measurement of certain
liabilities from non-functional currencies to functional currencies.
MetLife believes that excluding the impact of asymmetrical and
non-economic accounting from total GAAP results enhances investor
understanding of MetLife's performance by disclosing how these
accounting practices affect reported GAAP results.
-
MetLife uses a measure of free cash flow to facilitate an
understanding of its ability to generate cash for reinvestment into
its businesses or use in non-mandatory capital actions. MetLife
defines free cash flow as the sum of cash available at MetLife's
holding companies from dividends from adjusted subsidiaries, expenses
and other net flows of the holding companies (including capital
contributions to subsidiaries), and net contributions from debt to be
at or below target leverage ratios. This measure of free cash flow is
prior to capital actions, such as common stock dividends and
repurchases, debt reduction and mergers and acquisitions. Free cash
flow should not be viewed as a substitute for net cash provided by
(used in) adjusted activities calculated in accordance with GAAP. The
free cash flow ratio is typically expressed as a percentage of annual
adjusted earnings available to common shareholders.
-
Notable items represent a positive (negative) impact to adjusted
earnings available to common shareholders. Notable items reflect the
unexpected impact of events that affect the company's results, but
that were unknown and that the company could not anticipate when it
devised its Business Plan. Notable items also include certain items
regardless of the extent anticipated in the Business Plan, to help
investors have a better understanding of company results and to
evaluate and forecast those results.
Forward-Looking Statements
This news release may contain or incorporate by reference information
that includes or is based upon forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995.
Forward-looking statements give expectations or forecasts of future
events. These statements can be identified by the fact that they do not
relate strictly to historical or current facts. They use words such as
"anticipate," "estimate," "expect," "project," "intend," "plan,"
"believe," "will be," "will not," and other words and terms of similar
meaning, or are tied to future periods, in connection with a discussion
of future financial performance. In particular, these include statements
relating to future actions, prospective services or products, future
performance or results of current and anticipated services or products,
sales efforts, expenses, the outcome of contingencies such as legal
proceedings, trends in operations and financial results.
Any or all forward-looking statements may turn out to be wrong. They can
be affected by inaccurate assumptions or by known or unknown risks and
uncertainties. Many such factors will be important in determining the
actual future results of MetLife, Inc., its subsidiaries and affiliates.
These statements are based on current expectations and the current
economic environment. They involve a number of risks and uncertainties
that are difficult to predict. These statements are not guarantees of
future performance. Actual results could differ materially from those
expressed or implied in the forward-looking statements. Risks,
uncertainties, and other factors that might cause such differences
include the risks, uncertainties and other factors identified in
MetLife, Inc.'s filings with the U.S. Securities and Exchange
Commission. These factors include: (1) adverse effects which may arise
in connection with the material weakness in our internal control over
financial reporting or our failure to promptly remediate it; (2)
difficult conditions in the global capital markets; (3) increased
volatility and disruption of the global capital and credit markets,
which may affect our ability to meet liquidity needs and access capital,
including through our credit facilities, generate fee income and
market-related revenue and finance statutory reserve requirements and
may require us to pledge collateral or make payments related to declines
in value of specified assets, including assets supporting risks ceded to
certain of our captive reinsurers or hedging arrangements associated
with those risks; (4) exposure to global financial and capital market
risks, including as a result of the United Kingdom's notice of
withdrawal from the European Union, other disruption in Europe and
possible withdrawal of one or more countries from the Euro zone;
(5) impact on us of comprehensive financial services regulation reform,
including potential regulation of MetLife, Inc. as a non-bank
systemically important financial institution, or otherwise; (6) numerous
rulemaking initiatives required or permitted by the Dodd-Frank Wall
Street Reform and Consumer Protection Act which may impact how we
conduct our business, including those compelling the liquidation of
certain financial institutions; (7) regulatory, legislative or tax
changes relating to our insurance, international, or other operations
that may affect the cost of, or demand for, our products or services, or
increase the cost or administrative burdens of providing benefits to
employees; (8) adverse results or other consequences from litigation,
arbitration or regulatory investigations; (9) unanticipated or adverse
developments that could adversely affect our achieving expected
operational or other benefits from the separation of Brighthouse
Financial, Inc. and its subsidiaries ("Brighthouse"); (10) our equity
market exposure to Brighthouse Financial, Inc. following the separation
of Brighthouse; (11) liabilities, losses or indemnification obligations
arising from our transitional services, investment management or tax
arrangements or other agreements with Brighthouse; (12) failure of the
separation of Brighthouse to qualify for intended tax-free treatment;
(13) our ability to address difficulties, unforeseen liabilities, asset
impairments, or rating agency actions arising from (a) business
acquisitions and integrating and managing the growth of such acquired
businesses, (b) dispositions of businesses via sale, initial public
offering, spin-off or otherwise, including failure to achieve projected
operational benefit from such transactions and any restrictions,
liabilities, losses or indemnification obligations arising from any
transitional services or tax arrangements related to the separation of
any business, or from the failure of such a separation to qualify for
any intended tax-free treatment, (c) entry into joint ventures, or (d)
legal entity reorganizations; (14) potential liquidity and other risks
resulting from our participation in a securities lending program and
other transactions; (15) investment losses and defaults, and changes to
investment valuations; (16) changes in assumptions related to investment
valuations, deferred policy acquisition costs, deferred sales
inducements, value of business acquired or goodwill; (17) impairments of
goodwill and realized losses or market value impairments to illiquid
assets; (18) defaults on our mortgage loans; (19) the defaults or
deteriorating credit of other financial institutions that could
adversely affect us; (20) economic, political, legal, currency and other
risks relating to our international operations, including with respect
to fluctuations of exchange rates; (21) downgrades in our claims paying
ability, financial strength or credit ratings; (22) a deterioration in
the experience of the closed block established in connection with the
reorganization of Metropolitan Life Insurance Company; (23) availability
and effectiveness of reinsurance, hedging or indemnification
arrangements, as well as any default or failure of counterparties to
perform; (24) differences between actual claims experience and
underwriting and reserving assumptions; (25) ineffectiveness of risk
management policies and procedures; (26) catastrophe losses;
(27) increasing cost and limited market capacity for statutory life
insurance reserve financings; (28) heightened competition, including
with respect to pricing, entry of new competitors, consolidation of
distributors, the development of new products by new and existing
competitors, and for personnel; (29) exposure to losses related to
variable annuity guarantee benefits, including from significant and
sustained downturns or extreme volatility in equity markets, reduced
interest rates, unanticipated policyholder behavior, mortality or
longevity, and any adjustment for nonperformance risk; (30) legal,
regulatory and other restrictions affecting MetLife, Inc.'s ability to
pay dividends and repurchase common stock; (31) MetLife, Inc.'s and its
subsidiary holding companies' primary reliance, as holding companies, on
dividends from subsidiaries to meet free cash flow targets and debt
payment obligations and the applicable regulatory restrictions on the
ability of the subsidiaries to pay such dividends; (32) the possibility
that MetLife, Inc.'s Board of Directors may influence the outcome of
stockholder votes through the voting provisions of the MetLife
Policyholder Trust; (33) changes in accounting standards, practices
and/or policies; (34) increased expenses relating to pension and
postretirement benefit plans, as well as health care and other employee
benefits; (35) inability to protect our intellectual property rights or
claims of infringement of the intellectual property rights of others;
(36) difficulties in marketing and distributing products through our
distribution channels; (37) provisions of laws and our incorporation
documents that may delay, deter or prevent takeovers and corporate
combinations involving MetLife; (38) the effects of business disruption
or economic contraction due to disasters such as terrorist attacks,
cyberattacks, other hostilities, or natural catastrophes, including any
related impact on the value of our investment portfolio, our disaster
recovery systems, cyber- or other information security systems and
management continuity planning; (39) any failure to protect the
confidentiality of client information; (40) the effectiveness of our
programs and practices in avoiding giving our associates incentives to
take excessive risks; and (41) other risks and uncertainties described
from time to time in MetLife, Inc.'s filings with the U.S. Securities
and Exchange Commission.
MetLife, Inc. does not undertake any obligation to publicly correct or
update any forward-looking statement if MetLife, Inc. later becomes
aware that such statement is not likely to be achieved. Please consult
any further disclosures MetLife, Inc. makes on related subjects in
reports to the U.S. Securities and Exchange Commission.
|
MetLife, Inc.
|
GAAP Consolidated Statements of Operations
|
(Unaudited)
|
(In millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three Months Ended
|
|
For the Year Ended
|
|
|
|
December 31,
|
|
December 31,
|
|
|
|
2017
|
|
2016
|
|
2017
|
|
2016
|
Revenues
|
|
|
|
|
|
|
|
|
|
Premiums
|
|
|
$
|
9,571
|
|
|
$
|
9,246
|
|
|
$
|
38,992
|
|
|
$
|
37,202
|
|
Universal life and investment-type product policy fees
|
|
|
1,358
|
|
|
1,355
|
|
|
5,510
|
|
|
5,483
|
|
Net investment income
|
|
|
4,454
|
|
|
4,263
|
|
|
17,363
|
|
|
16,790
|
|
Other revenues
|
|
|
406
|
|
|
376
|
|
|
1,341
|
|
|
1,685
|
|
Net investment gains (losses)
|
|
|
106
|
|
|
(299
|
)
|
|
(308
|
)
|
|
317
|
|
Net derivative gains (losses)
|
|
|
(141
|
)
|
|
(2,312
|
)
|
|
(804
|
)
|
|
(874
|
)
|
Total revenues
|
|
|
15,754
|
|
|
12,629
|
|
|
62,094
|
|
|
60,603
|
|
|
|
|
|
|
|
|
.
|
|
|
Expenses
|
|
|
|
|
|
|
|
|
|
Policyholder benefits and claims
|
|
|
9,295
|
|
|
8,928
|
|
|
38,313
|
|
|
36,358
|
|
Interest credited to policyholder account balances
|
|
|
1,526
|
|
|
1,357
|
|
|
5,607
|
|
|
5,176
|
|
Policyholder dividends
|
|
|
306
|
|
|
299
|
|
|
1,231
|
|
|
1,223
|
|
Capitalization of DAC
|
|
|
(784
|
)
|
|
(730
|
)
|
|
(3,002
|
)
|
|
(3,152
|
)
|
Amortization of DAC and VOBA
|
|
|
736
|
|
|
654
|
|
|
2,681
|
|
|
2,718
|
|
Amortization of negative VOBA
|
|
|
(27
|
)
|
|
(48
|
)
|
|
(140
|
)
|
|
(269
|
)
|
Interest expense on debt
|
|
|
278
|
|
|
282
|
|
|
1,129
|
|
|
1,157
|
|
Other expenses
|
|
|
3,549
|
|
|
3,316
|
|
|
12,953
|
|
|
13,295
|
|
Total expenses
|
|
|
14,879
|
|
|
14,058
|
|
|
58,772
|
|
|
56,506
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from continuing operations before provision for income
tax
|
|
|
875
|
|
|
(1,429
|
)
|
|
3,322
|
|
|
4,097
|
|
Provision for income tax expense (benefit)
|
|
|
(1,259
|
)
|
|
(616
|
)
|
|
(1,420
|
)
|
|
629
|
|
Income (loss) from continuing operations, net of income tax
|
|
|
2,134
|
|
|
(813
|
)
|
|
4,742
|
|
|
3,468
|
|
Income (loss) from discontinued operations, net of income tax
|
|
|
-
|
|
|
(1,370
|
)
|
|
(986
|
)
|
|
(2,734
|
)
|
Net income (loss)
|
|
|
2,134
|
|
|
(2,183
|
)
|
|
3,756
|
|
|
734
|
|
Less: Net income (loss) attributable to noncontrolling interests
|
|
|
(2
|
)
|
|
2
|
|
|
10
|
|
|
4
|
|
Net income (loss) attributable to MetLife, Inc.
|
|
|
2,136
|
|
|
(2,185
|
)
|
|
3,746
|
|
|
730
|
|
Less: Preferred stock dividends
|
|
|
45
|
|
|
45
|
|
|
103
|
|
|
103
|
|
Net income (loss) available to MetLife, Inc.'s common shareholders
|
|
|
$
|
2,091
|
|
|
$
|
(2,230
|
)
|
|
$
|
3,643
|
|
|
$
|
627
|
|
|
|
|
|
|
|
|
|
|
|
See footnotes on last page.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MetLife, Inc.
|
(Unaudited)
|
(In millions, except per share data)
|
|
|
|
|
|
|
|
|
|
For the Three Months Ended
|
|
For the Year Ended
|
|
|
|
December 31,
|
|
December 31,
|
|
|
|
2017
|
|
2016
|
|
2017
|
|
2016
|
Reconciliation to Adjusted Earnings Available to Common
Shareholders
|
|
|
|
|
Earnings Per Weighted Average Common Shares Diluted (1)
|
|
|
|
Earnings Per Weighted Average Common Shares Diluted (1),
(2)
|
|
|
|
Earnings Per Weighted Average Common Shares Diluted (1)
|
|
|
|
Earnings Per Weighted Average Common Shares Diluted (1)
|
Net income (loss) available to MetLife, Inc.'s common shareholders
|
|
|
$
|
2,091
|
|
|
$
|
1.97
|
|
|
$
|
(2,230
|
)
|
|
$
|
(2.03
|
)
|
|
$
|
3,643
|
|
|
$
|
3.38
|
|
|
$
|
627
|
|
|
$
|
0.57
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjustments from net income (loss) available to common shareholders
to adjusted earnings available to common shareholders:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Less: Net investment gains (losses)
|
|
|
106
|
|
|
0.10
|
|
|
(299
|
)
|
|
(0.27
|
)
|
|
(308
|
)
|
|
(0.29
|
)
|
|
317
|
|
|
0.29
|
|
Net derivative gains (losses)
|
|
|
(141
|
)
|
|
(0.13
|
)
|
|
(2,312
|
)
|
|
(2.09
|
)
|
|
(804
|
)
|
|
(0.75
|
)
|
|
(874
|
)
|
|
(0.80
|
)
|
Premiums
|
|
|
-
|
|
|
-
|
|
|
(205
|
)
|
|
(0.18
|
)
|
|
(347
|
)
|
|
(0.32
|
)
|
|
(303
|
)
|
|
(0.27
|
)
|
Universal life and investment-type product policy fees
|
|
|
29
|
|
|
0.03
|
|
|
15
|
|
|
0.01
|
|
|
103
|
|
|
0.10
|
|
|
152
|
|
|
0.14
|
|
Net investment income
|
|
|
351
|
|
|
0.33
|
|
|
127
|
|
|
0.11
|
|
|
819
|
|
|
0.75
|
|
|
353
|
|
|
0.32
|
|
Other revenues
|
|
|
6
|
|
|
0.01
|
|
|
31
|
|
|
0.03
|
|
|
(113
|
)
|
|
(0.10
|
)
|
|
42
|
|
|
0.04
|
|
Policyholder benefits and claims and policyholder dividends
|
|
|
2
|
|
|
-
|
|
|
239
|
|
|
0.22
|
|
|
(204
|
)
|
|
(0.19
|
)
|
|
295
|
|
|
0.27
|
|
Interest credited to policyholder account balances
|
|
|
(420
|
)
|
|
(0.40
|
)
|
|
(331
|
)
|
|
(0.31
|
)
|
|
(1,294
|
)
|
|
(1.20
|
)
|
|
(1,088
|
)
|
|
(0.99
|
)
|
Capitalization of DAC
|
|
|
-
|
|
|
-
|
|
|
(21
|
)
|
|
(0.02
|
)
|
|
(34
|
)
|
|
(0.03
|
)
|
|
1
|
|
|
-
|
|
Amortization of DAC and VOBA
|
|
|
7
|
|
|
0.01
|
|
|
22
|
|
|
0.02
|
|
|
(33
|
)
|
|
(0.03
|
)
|
|
325
|
|
|
0.29
|
|
Amortization of negative VOBA
|
|
|
1
|
|
|
-
|
|
|
4
|
|
|
-
|
|
|
9
|
|
|
0.01
|
|
|
47
|
|
|
0.04
|
|
Interest expense on debt
|
|
|
-
|
|
|
-
|
|
|
12
|
|
|
0.01
|
|
|
16
|
|
|
0.01
|
|
|
50
|
|
|
0.05
|
|
Other expenses
|
|
|
(272
|
)
|
|
(0.26
|
)
|
|
(4
|
)
|
|
-
|
|
|
(544
|
)
|
|
(0.50
|
)
|
|
(355
|
)
|
|
(0.32
|
)
|
Goodwill impairment
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
|
Provision for income tax (expense) benefit
|
|
|
1,742
|
|
|
1.64
|
|
|
807
|
|
|
0.73
|
|
|
3,138
|
|
|
2.91
|
|
|
370
|
|
|
0.33
|
|
Income (loss) from discontinued operations, net of income tax
|
|
|
-
|
|
|
-
|
|
|
(1,370
|
)
|
|
(1.24
|
)
|
|
(986
|
)
|
|
(0.91
|
)
|
|
(2,734
|
)
|
|
(2.46
|
)
|
Add: Net income (loss) attributable to noncontrolling interests
|
|
|
(2
|
)
|
|
-
|
|
|
2
|
|
|
-
|
|
|
10
|
|
|
0.01
|
|
|
4
|
|
|
-
|
|
Adjusted earnings available to common shareholders
|
|
|
678
|
|
|
0.64
|
|
|
1,057
|
|
|
0.95
|
|
|
4,235
|
|
|
3.93
|
|
|
4,033
|
|
|
3.64
|
|
Less: Total notable items (3)
|
|
|
(498
|
)
|
|
(0.47
|
)
|
|
(142
|
)
|
|
(0.13
|
)
|
|
(622
|
)
|
|
(0.58
|
)
|
|
(709
|
)
|
|
(0.64
|
)
|
Adjusted earnings available to common shareholders, excluding total
notable items (3)
|
|
|
$
|
1,176
|
|
|
$
|
1.11
|
|
|
$
|
1,199
|
|
|
$
|
1.08
|
|
|
$
|
4,857
|
|
|
$
|
4.50
|
|
|
$
|
4,742
|
|
|
$
|
4.28
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted earnings available to common shareholders on a constant
currency basis
|
|
|
$
|
678
|
|
|
$
|
0.64
|
|
|
$
|
1,062
|
|
|
$
|
0.96
|
|
|
$
|
4,235
|
|
|
$
|
3.93
|
|
|
$
|
4,011
|
|
|
$
|
3.62
|
|
Adjusted earnings available to common shareholders, excluding total
notable items, on a constant currency basis (3)
|
|
|
$
|
1,176
|
|
|
$
|
1.11
|
|
|
$
|
1,204
|
|
|
$
|
1.09
|
|
|
$
|
4,857
|
|
|
$
|
4.50
|
|
|
$
|
4,720
|
|
|
$
|
4.26
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average common shares outstanding - diluted
|
|
|
|
|
1,062.1
|
|
|
|
|
1,108.8
|
|
|
|
|
1,078.5
|
|
|
|
|
1,108.5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
See footnotes on last page.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MetLife, Inc.
|
(Unaudited)
|
(In millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three Months Ended
|
|
For the Year Ended
|
|
|
|
December 31,
|
|
December 31,
|
|
|
|
2017
|
|
2016
|
|
2017
|
|
2016
|
Premiums, Fees and Other Revenues
|
|
|
|
|
|
|
|
|
|
Total premiums, fees and other revenues
|
|
|
$
|
11,335
|
|
|
$
|
10,977
|
|
|
$
|
45,843
|
|
|
$
|
44,370
|
|
Less: Unearned revenue adjustments
|
|
|
(2
|
)
|
|
2
|
|
|
12
|
|
|
30
|
|
GMIB fees
|
|
|
31
|
|
|
31
|
|
|
125
|
|
|
124
|
|
Settlement of foreign currency earnings hedges
|
|
|
6
|
|
|
(2
|
)
|
|
22
|
|
|
4
|
|
Divested businesses and Lag elimination (4)
|
|
|
-
|
|
|
(190
|
)
|
|
(516
|
)
|
|
(267
|
)
|
Total adjusted premiums, fees and other revenues
|
|
|
$
|
11,300
|
|
|
$
|
11,136
|
|
|
$
|
46,200
|
|
|
$
|
44,479
|
|
|
|
|
|
|
|
|
|
|
|
Net Investment Income
|
|
|
|
|
|
|
|
|
|
Net investment income
|
|
|
$
|
4,454
|
|
|
$
|
4,263
|
|
|
$
|
17,363
|
|
|
$
|
16,790
|
|
Less: Investment hedge adjustments
|
|
|
(85
|
)
|
|
(152
|
)
|
|
(435
|
)
|
|
(580
|
)
|
Operating joint venture adjustments
|
|
|
-
|
|
|
1
|
|
|
-
|
|
|
6
|
|
Unit-linked contract income
|
|
|
436
|
|
|
327
|
|
|
1,300
|
|
|
950
|
|
Securitization entities income
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
|
Divested businesses and Lag elimination (4)
|
|
|
-
|
|
|
(49
|
)
|
|
(46
|
)
|
|
(23
|
)
|
Net investment income, as reported on an adjusted basis
|
|
|
$
|
4,103
|
|
|
$
|
4,136
|
|
|
$
|
16,544
|
|
|
$
|
16,437
|
|
|
|
|
|
|
|
|
|
|
|
Revenues and Expenses
|
|
|
|
|
|
|
|
|
|
Total revenues
|
|
|
$
|
15,754
|
|
|
$
|
12,629
|
|
|
$
|
62,094
|
|
|
$
|
60,603
|
|
Less: Net investment (gains) losses
|
|
|
106
|
|
|
(299
|
)
|
|
(308
|
)
|
|
317
|
|
Less: Net derivative (gains) losses
|
|
|
(141
|
)
|
|
(2,312
|
)
|
|
(804
|
)
|
|
(874
|
)
|
Less: Adjustments related to net investment gains (losses) and net
derivative gains (losses)
|
|
|
(2
|
)
|
|
2
|
|
|
12
|
|
|
30
|
|
Less: Other adjustments to revenues:
|
|
|
|
|
|
|
|
|
|
GMIB fees
|
|
|
31
|
|
|
31
|
|
|
125
|
|
|
124
|
|
Investment hedge adjustments
|
|
|
(85
|
)
|
|
(152
|
)
|
|
(435
|
)
|
|
(580
|
)
|
Operating joint venture adjustments
|
|
|
-
|
|
|
1
|
|
|
-
|
|
|
6
|
|
Unit-linked contract income
|
|
|
436
|
|
|
327
|
|
|
1,300
|
|
|
950
|
|
Securitization entities income
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
|
Settlement of foreign currency earnings hedges
|
|
|
6
|
|
|
(2
|
)
|
|
22
|
|
|
4
|
|
Divested businesses and Lag elimination (4)
|
|
|
-
|
|
|
(239
|
)
|
|
(562
|
)
|
|
(290
|
)
|
Total adjusted revenues
|
|
|
$
|
15,403
|
|
|
$
|
15,272
|
|
|
$
|
62,744
|
|
|
$
|
60,916
|
|
|
|
|
|
|
|
|
|
|
|
Total expenses
|
|
|
$
|
14,879
|
|
|
$
|
14,058
|
|
|
$
|
58,772
|
|
|
$
|
56,506
|
|
Less: Adjustments related to net investment (gains) losses and net
derivative (gains) losses
|
|
|
(28
|
)
|
|
(11
|
)
|
|
(60
|
)
|
|
(226
|
)
|
Less: Goodwill impairment
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
|
Less: Other adjustments to expenses:
|
|
|
|
|
|
|
|
|
|
Inflation and pass through adjustments
|
|
|
(77
|
)
|
|
(163
|
)
|
|
(31
|
)
|
|
(85
|
)
|
GMIB costs and amortization of DAC and VOBA related to GMIB fees and
GMIB costs
|
|
|
93
|
|
|
100
|
|
|
352
|
|
|
125
|
|
Market value adjustments and amortization of DAC, VOBA and negative
VOBA related to market value adjustments
|
|
|
2
|
|
|
6
|
|
|
13
|
|
|
16
|
|
PAB hedge adjustments
|
|
|
-
|
|
|
(1
|
)
|
|
(3
|
)
|
|
(3
|
)
|
Unit-linked contract costs
|
|
|
420
|
|
|
318
|
|
|
1,264
|
|
|
932
|
|
Securitization entities debt expense
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
|
Noncontrolling interest
|
|
|
5
|
|
|
(4
|
)
|
|
(12
|
)
|
|
(6
|
)
|
Regulatory implementation costs
|
|
|
-
|
|
|
1
|
|
|
-
|
|
|
1
|
|
Acquisition, integration and other costs
|
|
|
23
|
|
|
31
|
|
|
65
|
|
|
64
|
|
Divested businesses and Lag elimination (4)
|
|
|
244
|
|
|
(198
|
)
|
|
496
|
|
|
(93
|
)
|
Total adjusted expenses
|
|
|
$
|
14,197
|
|
|
$
|
13,979
|
|
|
$
|
56,688
|
|
|
$
|
55,781
|
|
|
|
|
|
|
|
|
|
|
|
See footnotes on last page.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MetLife, Inc.
|
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
|
Book Value (5)
|
|
2017
|
|
2016
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Book value per common share
|
|
$
|
53.57
|
|
|
$
|
59.35
|
|
|
|
|
|
Less: Net unrealized investment gains (losses), net of income tax
|
|
13.10
|
|
|
11.54
|
|
|
|
|
|
Defined benefit plans adjustment, net of income tax
|
|
(1.77
|
)
|
|
(1.80
|
)
|
|
|
|
|
Book value per common share, excluding AOCI other than FCTA
|
|
42.24
|
|
|
49.61
|
|
|
|
|
|
Less: Goodwill, net of income tax
|
|
8.93
|
|
|
8.32
|
|
|
|
|
|
VODA and VOCRA, net of income tax
|
|
0.36
|
|
|
0.37
|
|
|
|
|
|
Book value per common share - tangible common stockholders' equity
|
|
$
|
32.95
|
|
|
$
|
40.92
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Book value per common share
|
|
$
|
53.57
|
|
|
$
|
59.35
|
|
|
|
|
|
Less: Net unrealized investment gains (losses), net of income tax
|
|
13.10
|
|
|
11.54
|
|
|
|
|
|
Defined benefit plans adjustment, net of income tax
|
|
(1.77
|
)
|
|
(1.80
|
)
|
|
|
|
|
Book value per common share, excluding AOCI other than FCTA
|
|
42.24
|
|
|
49.61
|
|
|
|
|
|
Less: Net equity of assets and liabilities of disposed subsidiary,
excluding AOCI other than FCTA
|
|
-
|
|
|
15.16
|
|
|
|
|
|
Book value per common share - common stockholders' equity, excluding
net equity of assets and liabilities of disposed subsidiary
(excludes AOCI other than FCTA)
|
|
$
|
42.24
|
|
|
$
|
34.45
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common shares outstanding, end of period (In millions)
|
|
1,043.6
|
|
|
1,095.5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three Months Ended
|
|
For the Year Ended
|
|
|
December 31, (6)
|
|
December 31,
|
Return on Equity
|
|
2017
|
|
2016
|
|
2017
|
|
2016
|
Return on MetLife, Inc.'s:
|
|
|
|
|
|
|
|
|
Common stockholders' equity
|
|
15.2
|
%
|
|
(12.6
|
)%
|
|
5.9
|
%
|
|
0.9
|
%
|
Common stockholders' equity, excluding AOCI other than FCTA
|
|
19.2
|
%
|
|
(15.8
|
)%
|
|
7.3
|
%
|
|
1.1
|
%
|
Tangible common stockholders' equity
|
|
24.8
|
%
|
|
(19.0
|
)%
|
|
9.1
|
%
|
|
1.4
|
%
|
|
|
|
|
|
|
|
|
|
Adjusted return on MetLife, Inc.'s:
|
|
|
|
|
|
|
|
|
Common stockholders' equity
|
|
4.9
|
%
|
|
6.0
|
%
|
|
6.9
|
%
|
|
5.6
|
%
|
Common stockholders' equity, excluding AOCI other than FCTA
|
|
6.2
|
%
|
|
7.5
|
%
|
|
8.5
|
%
|
|
7.1
|
%
|
Common stockholders' equity, excluding total notable items (excludes
AOCI other than FCTA) (3), (7)
|
|
10.7
|
%
|
|
8.5
|
%
|
|
9.7
|
%
|
|
8.3
|
%
|
Common stockholders' equity, excluding net equity of assets and
liabilities of disposed subsidiary (excludes AOCI other than FCTA)
|
|
6.2
|
%
|
|
10.8
|
%
|
|
10.5
|
%
|
|
10.4
|
%
|
Tangible common stockholders' equity
|
|
8.1
|
%
|
|
9.1
|
%
|
|
10.6
|
%
|
|
8.6
|
%
|
Tangible common stockholders' equity, excluding total notable items
(3), (7)
|
|
13.9
|
%
|
|
10.3
|
%
|
|
12.1
|
%
|
|
10.1
|
%
|
|
|
|
|
|
|
|
|
|
Return on Allocated Equity:
|
|
|
|
|
|
|
|
|
U.S.
|
|
21.5
|
%
|
|
6.0
|
%
|
|
|
|
|
Asia
|
|
11.8
|
%
|
|
(21.7
|
)%
|
|
|
|
|
Latin America
|
|
8.0
|
%
|
|
32.7
|
%
|
|
|
|
|
EMEA
|
|
11.3
|
%
|
|
3.2
|
%
|
|
|
|
|
MetLife Holdings
|
|
3.0
|
%
|
|
(14.5
|
)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Return on Allocated Tangible Equity:
|
|
|
|
|
|
|
|
|
U.S.
|
|
25.0
|
%
|
|
6.6
|
%
|
|
|
|
|
Asia
|
|
18.8
|
%
|
|
(37.2
|
)%
|
|
|
|
|
Latin America
|
|
13.8
|
%
|
|
51.9
|
%
|
|
|
|
|
EMEA
|
|
18.4
|
%
|
|
6.0
|
%
|
|
|
|
|
MetLife Holdings
|
|
3.4
|
%
|
|
(15.0
|
)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted Return on Allocated Equity:
|
|
|
|
|
|
|
|
|
U.S.
|
|
19.5
|
%
|
|
18.9
|
%
|
|
|
|
|
Asia
|
|
9.9
|
%
|
|
12.8
|
%
|
|
|
|
|
Latin America
|
|
17.0
|
%
|
|
15.9
|
%
|
|
|
|
|
EMEA
|
|
9.8
|
%
|
|
8.9
|
%
|
|
|
|
|
MetLife Holdings
|
|
6.9
|
%
|
|
7.3
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted Return on Allocated Tangible Equity:
|
|
|
|
|
|
|
|
|
U.S.
|
|
22.7
|
%
|
|
20.8
|
%
|
|
|
|
|
Asia
|
|
15.8
|
%
|
|
22.1
|
%
|
|
|
|
|
Latin America
|
|
29.3
|
%
|
|
25.2
|
%
|
|
|
|
|
EMEA
|
|
16.1
|
%
|
|
15.6
|
%
|
|
|
|
|
MetLife Holdings
|
|
7.8
|
%
|
|
7.8
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
See footnotes on last page.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MetLife, Inc.
|
Condensed Reconciliation of Net Cash Provided by Operating
Activities of MetLife, Inc.
|
to Free Cash Flow of All Holding Companies
|
(Unaudited)
|
|
|
|
|
|
|
|
|
|
For the Year Ended December 31,
|
|
|
|
2017
|
|
2016
|
|
|
|
(In billions, except ratios)
|
MetLife, Inc. (parent company only) net cash provided by operating
activities
|
|
|
$
|
6.5
|
|
|
$
|
3.7
|
|
Adjustments from net cash provided by operating activities to free
cash flow:
|
|
|
|
|
|
Add: Incremental debt to be at or below target leverage ratios
|
|
|
-
|
|
|
-
|
|
Add: Adjustments from net cash provided by operating activities to
free cash flow (8)
|
|
|
(0.3
|
)
|
|
(2.3
|
)
|
MetLife, Inc. (parent company only) free cash flow
|
|
|
6.2
|
|
|
1.4
|
|
Other MetLife, Inc. holding companies free cash flow (9)
|
|
|
(0.5
|
)
|
|
1.0
|
|
Free cash flow of all holding companies
|
|
|
$
|
5.7
|
|
|
$
|
2.4
|
|
|
|
|
|
|
|
Ratio of net cash provided by operating activities to
consolidated net income (loss) available to MetLife, Inc.'s common
shareholders:
|
|
|
|
|
|
MetLife, Inc. (parent company only) net cash provided by operating
activities
|
|
|
$
|
6.5
|
|
|
$
|
3.7
|
|
Consolidated net income (loss) available to MetLife, Inc.'s common
shareholders (10)
|
|
|
$
|
3.6
|
|
|
$
|
0.6
|
|
Ratio of net cash provided by operating activities (parent company
only) to consolidated net income (loss) available to MetLife, Inc.'s
common shareholders (10) (11)
|
|
|
177
|
%
|
|
598
|
%
|
|
|
|
|
|
|
Ratio of free cash flow to adjusted earnings available to common
shareholders:
|
|
|
|
|
|
Free cash flow of all holding companies (12)
|
|
|
$
|
5.7
|
|
|
$
|
2.4
|
|
Consolidated adjusted earnings available to common shareholders (12)
|
|
|
$
|
4.2
|
|
|
$
|
4.0
|
|
Ratio of free cash flow of all holding companies to consolidated
adjusted earnings available to common shareholders (12)
|
|
|
134
|
%
|
|
60
|
%
|
|
|
|
|
|
|
|
|
|
MetLife, Inc.
|
Adjusted Earnings Available to Common Shareholders
|
(Unaudited)
|
(In millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three Months Ended
|
|
For the Year Ended
|
|
|
|
|
December 31,
|
|
December 31,
|
|
|
|
|
2017
|
|
2016
|
|
2017
|
|
2016
|
U.S.:
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted earnings available to common shareholders
|
|
|
$
|
498
|
|
|
$
|
511
|
|
|
$
|
2,027
|
|
|
$
|
1,896
|
|
|
Less: Total notable items (3)
|
|
|
(55
|
)
|
|
-
|
|
|
(88
|
)
|
|
(101
|
)
|
|
Adjusted earnings available to common shareholders, excluding total
notable items (3)
|
|
|
$
|
553
|
|
|
$
|
511
|
|
|
$
|
2,115
|
|
|
$
|
1,997
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted earnings available to common shareholders on a constant
currency basis (13)
|
|
|
$
|
498
|
|
|
$
|
511
|
|
|
$
|
2,027
|
|
|
$
|
1,896
|
|
|
Adjusted earnings available to common shareholders, excluding total
notable items, on a constant currency basis (3), (13)
|
|
|
$
|
553
|
|
|
$
|
511
|
|
|
$
|
2,115
|
|
|
$
|
1,997
|
|
|
|
|
|
|
|
|
|
|
|
|
Group Benefits:
|
|
|
|
|
|
|
|
|
|
|
Adjusted earnings available to common shareholders
|
|
|
$
|
230
|
|
|
$
|
174
|
|
|
$
|
868
|
|
|
$
|
687
|
|
|
Less: Total notable items (3)
|
|
|
-
|
|
|
-
|
|
|
3
|
|
|
9
|
|
|
Adjusted earnings available to common shareholders, excluding total
notable items (3)
|
|
|
$
|
230
|
|
|
$
|
174
|
|
|
$
|
865
|
|
|
$
|
678
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted earnings available to common shareholders on a constant
currency basis (13)
|
|
|
$
|
230
|
|
|
$
|
174
|
|
|
$
|
868
|
|
|
$
|
687
|
|
|
Adjusted earnings available to common shareholders, excluding total
notable items, on a constant currency basis (3), (13)
|
|
|
$
|
230
|
|
|
$
|
174
|
|
|
$
|
865
|
|
|
$
|
678
|
|
|
|
|
|
|
|
|
|
|
|
|
Retirement & Income Solutions:
|
|
|
|
|
|
|
|
|
|
|
Adjusted earnings available to common shareholders
|
|
|
$
|
173
|
|
|
$
|
294
|
|
|
$
|
956
|
|
|
$
|
1,088
|
|
|
Less: Total notable items (3)
|
|
|
(62
|
)
|
|
-
|
|
|
(45
|
)
|
|
(59
|
)
|
|
Adjusted earnings available to common shareholders, excluding total
notable items (3)
|
|
|
$
|
235
|
|
|
$
|
294
|
|
|
$
|
1,001
|
|
|
$
|
1,147
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted earnings available to common shareholders on a constant
currency basis (13)
|
|
|
$
|
173
|
|
|
$
|
294
|
|
|
$
|
956
|
|
|
$
|
1,088
|
|
|
Adjusted earnings available to common shareholders, excluding total
notable items, on a constant currency basis (3), (13)
|
|
|
$
|
235
|
|
|
$
|
294
|
|
|
$
|
1,001
|
|
|
$
|
1,147
|
|
|
|
|
|
|
|
|
|
|
|
|
Property & Casualty:
|
|
|
|
|
|
|
|
|
|
|
Adjusted earnings available to common shareholders
|
|
|
$
|
95
|
|
|
$
|
43
|
|
|
$
|
203
|
|
|
$
|
121
|
|
|
Less: Total notable items (3)
|
|
|
7
|
|
|
-
|
|
|
(46
|
)
|
|
(51
|
)
|
|
Adjusted earnings available to common shareholders, excluding total
notable items (3)
|
|
|
$
|
88
|
|
|
$
|
43
|
|
|
$
|
249
|
|
|
$
|
172
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted earnings available to common shareholders on a constant
currency basis (13)
|
|
|
$
|
95
|
|
|
$
|
43
|
|
|
$
|
203
|
|
|
$
|
121
|
|
|
Adjusted earnings available to common shareholders, excluding total
notable items, on a constant currency basis (3), (13)
|
|
|
$
|
88
|
|
|
$
|
43
|
|
|
$
|
249
|
|
|
$
|
172
|
|
|
|
|
|
|
|
|
|
|
|
|
Asia:
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted earnings available to common shareholders
|
|
|
$
|
310
|
|
|
$
|
354
|
|
|
$
|
1,229
|
|
|
$
|
1,224
|
|
|
Less: Total notable items (3)
|
|
|
-
|
|
|
-
|
|
|
5
|
|
|
(91
|
)
|
|
Adjusted earnings available to common shareholders, excluding total
notable items (3)
|
|
|
$
|
310
|
|
|
$
|
354
|
|
|
$
|
1,224
|
|
|
$
|
1,315
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted earnings available to common shareholders on a constant
currency basis
|
|
|
$
|
310
|
|
|
$
|
353
|
|
|
$
|
1,229
|
|
|
$
|
1,216
|
|
|
Adjusted earnings available to common shareholders, excluding total
notable items, on a constant currency basis (3)
|
|
|
$
|
310
|
|
|
$
|
353
|
|
|
$
|
1,224
|
|
|
$
|
1,307
|
|
|
|
|
|
|
|
|
|
|
|
|
Latin America:
|
|
|
|
|
|
|
|
|
|
|
Adjusted earnings available to common shareholders
|
|
|
$
|
125
|
|
|
$
|
122
|
|
|
$
|
585
|
|
|
$
|
543
|
|
|
Less: Total notable items (3)
|
|
|
-
|
|
|
-
|
|
|
14
|
|
|
(8
|
)
|
|
Adjusted earnings available to common shareholders, excluding total
notable items (3)
|
|
|
$
|
125
|
|
|
$
|
122
|
|
|
$
|
571
|
|
|
$
|
551
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted earnings available to common shareholders on a constant
currency basis
|
|
|
$
|
125
|
|
|
$
|
125
|
|
|
$
|
585
|
|
|
$
|
541
|
|
|
Adjusted earnings available to common shareholders, excluding total
notable items, on a constant currency basis (3)
|
|
|
$
|
125
|
|
|
$
|
125
|
|
|
$
|
571
|
|
|
$
|
549
|
|
|
|
|
|
|
|
|
|
|
|
|
EMEA:
|
|
|
|
|
|
|
|
|
|
|
Adjusted earnings available to common shareholders
|
|
|
$
|
79
|
|
|
$
|
72
|
|
|
$
|
297
|
|
|
$
|
273
|
|
|
Less: Total notable items (3)
|
|
|
-
|
|
|
-
|
|
|
(8
|
)
|
|
(16
|
)
|
|
Adjusted earnings available to common shareholders, excluding total
notable items (3)
|
|
|
$
|
79
|
|
|
$
|
72
|
|
|
$
|
305
|
|
|
$
|
289
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted earnings available to common shareholders on a constant
currency basis
|
|
|
$
|
79
|
|
|
$
|
75
|
|
|
$
|
297
|
|
|
$
|
261
|
|
|
Adjusted earnings available to common shareholders, excluding total
notable items, on a constant currency basis (3)
|
|
|
$
|
79
|
|
|
$
|
75
|
|
|
$
|
305
|
|
|
$
|
277
|
|
|
|
|
|
|
|
|
|
|
|
|
MetLife Holdings:
|
|
|
|
|
|
|
|
|
|
|
Adjusted earnings available to common shareholders
|
|
|
$
|
194
|
|
|
$
|
201
|
|
|
$
|
1,182
|
|
|
$
|
706
|
|
|
Less: Total notable items (3)
|
|
|
(48
|
)
|
|
(91
|
)
|
|
111
|
|
|
(433
|
)
|
|
Adjusted earnings available to common shareholders, excluding total
notable items (3)
|
|
|
$
|
242
|
|
|
$
|
292
|
|
|
$
|
1,071
|
|
|
$
|
1,139
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted earnings available to common shareholders on a constant
currency basis (13)
|
|
|
$
|
194
|
|
|
$
|
201
|
|
|
$
|
1,182
|
|
|
$
|
706
|
|
|
Adjusted earnings available to common shareholders, excluding total
notable items, on a constant currency basis (3), (13)
|
|
|
$
|
242
|
|
|
$
|
292
|
|
|
$
|
1,071
|
|
|
$
|
1,139
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate & Other:
|
|
|
|
|
|
|
|
|
|
|
Adjusted earnings available to common shareholders
|
|
|
$
|
(528
|
)
|
|
$
|
(203
|
)
|
|
$
|
(1,085
|
)
|
|
$
|
(609
|
)
|
|
Less: Total notable items (3)
|
|
|
(395
|
)
|
|
(51
|
)
|
|
(656
|
)
|
|
(60
|
)
|
|
Adjusted earnings available to common shareholders, excluding total
notable items (3)
|
|
|
$
|
(133
|
)
|
|
$
|
(152
|
)
|
|
$
|
(429
|
)
|
|
$
|
(549
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted earnings available to common shareholders on a constant
currency basis (13)
|
|
|
$
|
(528
|
)
|
|
$
|
(203
|
)
|
|
$
|
(1,085
|
)
|
|
$
|
(609
|
)
|
|
Adjusted earnings available to common shareholders, excluding total
notable items, on a constant currency basis (3), (13)
|
|
|
$
|
(133
|
)
|
|
$
|
(152
|
)
|
|
$
|
(429
|
)
|
|
$
|
(549
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
See footnotes on last page.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MetLife, Inc.
|
(Unaudited)
|
|
|
|
(1)
|
|
Adjusted earnings available to common shareholders is calculated on
a standalone basis and may not equal the sum of adjusted earnings
available to common shareholders, excluding total notable items and
total notable items.
|
|
|
|
(2)
|
|
8.6 million shares related to the assumed exercise or issuance of
stock-based awards for the three months ended December 31, 2016 have
been excluded from the weighted average common shares outstanding -
diluted, as to include these assumed shares would be anti-dilutive
to income (loss) from continuing operations, net of income tax, per
common share - diluted. These shares were included in the
calculation of adjusted earnings available to common shareholders
per common share - diluted.
|
|
|
|
(3)
|
|
Notable items reflect the unexpected impact of events that affect
the Company's results, but that were unknown and that the Company
could not anticipate when it devised its Business Plan. Notable
items also include certain items regardless of the extent
anticipated in the Business Plan to help investors have a better
understanding of Company results and to evaluate and forecast those
results. Notable items can affect the Company's results either
positively or negatively.
|
|
|
|
(4)
|
|
For the twelve months ended December 31, 2016, Divested businesses
and Lag elimination includes adjustments related to the financial
impact of converting MetLife's Japan operations to calendar year end
reporting without retrospective application of this change to prior
periods.
|
|
|
|
(5)
|
|
Book values exclude $2,066 million of equity related to preferred
stock at both December 30, 2017 and 2016.
|
|
|
|
(6)
|
|
Annualized using quarter-to-date results.
|
|
|
|
(7)
|
|
Excludes total notable items for the reported periods presented in
calculating the ratios.
|
|
|
|
(8)
|
|
Adjustments include: (i) capital contributions to subsidiaries; (ii)
returns of capital from subsidiaries; (iii) repayments on and
(issuances of) loans to subsidiaries, net; and (iv) investment
portfolio and derivatives changes and other, net.
|
|
|
|
(9)
|
|
Components include: (i) dividends and returns of capital from
subsidiaries; (ii) capital contributions from MetLife, Inc.; (iii)
capital contributions to subsidiaries; (iv) repayments on and
(issuances of) loans to subsidiaries, net; (v) other expenses; (vi)
dividends and returns of capital to MetLife, Inc. and (vii)
investment portfolio changes and other, net.
|
|
|
|
(10)
|
|
Consolidated net income (loss) available to MetLife, Inc.'s common
shareholders for 2017 includes Separation-related costs of $0.3
billion, net of income tax. Excluding this amount from the
denominator of the ratio, this ratio, as adjusted, would be 163%.
Consolidated net income (loss) available to MetLife, Inc.'s common
shareholders for 2016 includes Separation-related costs of $0.07
billion, net of income tax. Excluding this amount from the
denominator of the ratio, this ratio, as adjusted, would be 535%.
|
|
|
|
(11)
|
|
Including the free cash flow of other MetLife, Inc. holding
companies of ($0.5) billion and $1.0 billion for the years ended
December 31, 2017 and 2016, respectively, in the numerator of the
ratio, this ratio, as adjusted, would be 164% and 757%,
respectively. Including the free cash flow of other MetLife, Inc.
holding companies in the numerator of the ratio and excluding the
Separation-related costs from the denominator of the ratio, this
ratio, as adjusted, would be 151% and 679% for the years ended
December 31, 2017 and 2016, respectively.
|
|
|
|
(12)
|
|
i) In 2017, $2.1 billion of Separation-related items (comprised of
certain Separation-related inflows primarily related to dividends
from Brighthouse, net of outflows) were included, which increased
our holding companies' liquid assets, as well as our free cash flow.
Excluding these Separation-related items, adjusted free cash flow
would be $3.6 billion for the year ended December 31, 2017.
Consolidated adjusted earnings available to common shareholders for
2017 was negatively impacted by notable items, primarily related to
tax adjustments, of $0.6 billion, net of income tax. Excluding the
Separation-related items, which increased free cash flow, from the
numerator of the ratio and excluding such notable items and
Separation-related costs negatively impacting consolidated adjusted
earnings available to common shareholders from the denominator of
the ratio, the adjusted free cash flow ratio for 2017 would be 75%. ii)
In 2016, we incurred $2.3 billion of Separation-related items
(comprised of certain Separation-related outflows, net of inflows
related to dividends from Brighthouse subsidiaries) which reduced
our holding companies' liquid assets, as well as our free cash flow.
Excluding these Separation-related items, adjusted free cash flow
would be $4.7 billion for the year ended December 31, 2016.
Consolidated adjusted earnings available to common shareholders for
2016 was negatively impacted by notable items, primarily related to
the actuarial assumption review and other insurance adjustments, of
$0.7 billion, net of income tax, and Separation-related costs of
$0.02 billion, net of income tax. Excluding the Separation-related
items, which reduced free cash flow, from the numerator of the ratio
and excluding such notable items and Separation-related costs
negatively impacting consolidated adjusted earnings available to
common shareholders from the denominator of the ratio, the adjusted
free cash flow ratio for 2016 would be 98%.
|
|
|
|
(13)
|
|
Amounts on a reported basis, as constant currency impact is not
significant.
|
|
|
|
View source version on businesswire.com: http://www.businesswire.com/news/home/20180213006501/en/
[ Back To TMCnet.com's Homepage ]
|